Document Detail


The duration of residual neuromuscular block after administration of neostigmine or sugammadex at two visible twitches during train-of-four monitoring.
MedLine Citation:
PMID:  20978247     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Adequate recovery from neuromuscular block (NMB) is imperative for the patient to have full control of pharyngeal and respiratory muscles. The train-of-4 (TOF) ratio should return to at least 0.90 to exclude potentially clinically significant postoperative residual block. Fade cannot be detected reliably with a peripheral nerve stimulator (PNS) at a TOF ratio >0.4. The time gap between loss of visual fade by using a PNS until objective TOF ratio has returned to >0.90 can be considered "the potentially unsafe period of recovery." According to our hypothesis the duration of this period would be significantly shorter with sugammadex than with neostigmine.
METHODS: Fifty patients received volatile anesthetics, opioids, and a rocuronium-induced NMB. TOF-Watch without a preload was used, but the anesthesiologist relied on visual evaluation of the TOF responses only. At end of operation, patients were randomized to receive either neostigmine 50 μg/kg or sugammadex 2 mg/kg, when 2 twitch responses were detected after the last dose of rocuronium. Timing of tracheal extubation was based on PNS and clinical data. Duration of the potentially unsafe period of recovery after reversal by either neostigmine or sugammadex was analyzed. Mann-Whitney U test and Pearson χ(2) test were used for statistical analysis.
RESULTS: The times [mean ± sd (range)] from loss of visual fade to TOF ratio >0.90 were 10.3 ± 5.5 (1.3 to 26.0) minutes and 0.3 ± 0.3 (0.0 to 1.0) minutes in the neostigmine and sugammadex groups, respectively (P < 0.001). The times from reversal by neostigmine or sugammadex to TOF ratio >0.90 were 13.3 ± 5.7 (3.5 to 28.9) and 1.7 ± 0.7 (0.7 to 3.5) minutes, respectively (P < 0.001). The values of TOF ratios at the time of loss of visual fade were 0.34 ± 0.14 (0.00 to 0.56) in patients given neostigmine and 0.86 ± 0.11 (0.64 to 1.04) in patients given sugammadex (P < 0.001).
CONCLUSIONS: There is a significant time gap between visual loss of fade and return of TOF ratio >0.90 after reversal of a rocuronium block by neostigmine. Sugammadex in comparison with neostigmine allows a safer reversal of a moderate NMB when relying on visual evaluation of the TOF response.
Authors:
Hanna L Illman; Päivi Laurila; Heikki Antila; Olli A Meretoja; Seppo Alahuhta; Klaus T Olkkola
Related Documents :
11688777 - Results of neurilemoma treatment: a review of 78 cases.
1651857 - Is the diagnosis of significant residual neuromuscular blockade improved by using doubl...
8829417 - A comparison of meperidine and lidocaine for spinal anesthesia for postpartum tubal lig...
20014597 - Continuous intra-articular infusion of ropivacaine after unilateral total knee arthropl...
17425387 - Ensuring timely completion of type and screen testing and the verification of abo/rh st...
7128187 - Double-blind clinical evaluation of the relative efficacy of ibuprofen and glucosamine ...
Publication Detail:
Type:  Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't     Date:  2010-10-26
Journal Detail:
Title:  Anesthesia and analgesia     Volume:  112     ISSN:  1526-7598     ISO Abbreviation:  Anesth. Analg.     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2010-12-21     Completed Date:  2011-01-20     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  1310650     Medline TA:  Anesth Analg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  63-8     Citation Subset:  AIM; IM    
Affiliation:
Department of Anesthesiology, Intensive Care, Emergency Care and Pain Medicine, Turku University Hospital and University of Turku, Kiinamyllynkatu 4-8, PO Box 52, FI-20521 Turku, Finland. hanna.illman@tyks.fi
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Anesthesia Recovery Period*
Double-Blind Method
Female
Humans
Male
Middle Aged
Monitoring, Intraoperative / methods*
Neostigmine / administration & dosage*
Neuromuscular Blockade / methods*
Time Factors
Young Adult
gamma-Cyclodextrins / administration & dosage*
Chemical
Reg. No./Substance:
0/Sugammadex; 0/gamma-Cyclodextrins; 59-99-4/Neostigmine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Technical communication: respiratory variation in pulse pressure and plethysmographic waveforms: int...
Next Document:  Long-term cognitive impairment and functional disability among survivors of severe sepsis.